drugset / Trial / NCT00747071

Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies

NCT00747071 ↗

Phase 2/3 Withdrawn Hadassah Medical Organization
RandomizedSingle-groupQuadruple-blindPrevention

Summary

This clinical study is designed to evaluate the safety and efficacy of oral administration of the food additive colostrum derived antibodies to Clostridium difficile for prevention of Clostridium difficile associated disease (CDAD).

Timeline

Start
2011-09
Primary completion
2012-11
Completion
2013-11

Outcome

Outcome not reported

Stopped: “Sponsors decision”

Drugs

EvaluationDrugModalityDoseRoute
Subject Colostrum Protein / enzyme biologic — Oral